The incidence and outcomes of acute coronary syndromes in a central European country: results of the CZECH-2 registry
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
24602321
DOI
10.1016/j.ijcard.2014.02.013
PII: S0167-5273(14)00366-0
Knihovny.cz E-zdroje
- Klíčová slova
- Acute coronary syndrome, Incidence, Outcome, Registry,
- MeSH
- akutní koronární syndrom diagnóza mortalita terapie MeSH
- dostupnost zdravotnických služeb statistika a číselné údaje MeSH
- incidence MeSH
- infarkt myokardu diagnóza mortalita terapie MeSH
- koronární angioplastika mortalita MeSH
- lidé středního věku MeSH
- lidé MeSH
- mortalita v nemocnicích MeSH
- nemocnice statistika a číselné údaje MeSH
- nestabilní angina pectoris diagnóza mortalita terapie MeSH
- registrace statistika a číselné údaje MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
BACKGROUND: The incidence and treatment strategies of acute coronary syndrome (ACS) vary by region. Additionally, the clinical spectrum of ACS is changing and outcomes are improving. AIM: We assessed the incidence, treatment strategies, and outcomes of ACS for a well-defined population within a well-established network of percutaneous coronary intervention (PCI) centers and non-PCI centers. METHODS: The CZECH-2 registry included 1221 consecutive patients (mean age: 68 ± 13 years; 63.4% males) admitted for suspected ACS to 32 hospitals (including 4 PCI centers) within four Czech counties (total population: 2,370,841 inhabitants) during a 2-month period. RESULTS: The estimated incidence of confirmed ACS was 2,149 cases/million/year. In 374 (31%) patients, ACS was ruled out during the hospital stay. Coronary angiography (CAG) was performed in 60% of the patients overall and PCI was performed in 59% of the confirmed ACS patients. Killip classifications II-IV on admission were more common in patients with final diagnosis of non ST-elevation myocardial infarction (NSTEMI) than ST-elevation myocardial infarction (STEMI) (37.1% vs. 22.8%; p<0.001). The 30-day mortality rate was 5.7% for the whole study group, 7.3% for STEMI patients, 8.4% for NSTEMI patients, and 1.6% for patients with unstable angina pectoris (UAP), respectively. CONCLUSIONS: Almost one-third of the patients admitted for suspected ACS had a different final diagnosis. Among those with confirmed ACS, the use of CAG, PCI, CABG, and effective medications is rational. Outcome in NSTEMI patients was equivalent to those in STEMI patients, mainly due to the high-risk population in this group.
Cardiocenter Charles University Prague 3rd Faculty of Medicine Prague Czech Republic
Cardiocenter Hospital Liberec Liberec Czech Republic
Masaryk Hospital Department of Cardiology Usti nad Labem Czech Republic
Masaryk University Faculty of Medicine Institute for Biostatistics and Analysis Brno Czech Republic
Regional Hospital Department of Cardiology Ceske Budejovice Czech Republic
Citace poskytuje Crossref.org
Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 Pandemic
